Stoke Therapeutics, Inc. (STOK)
STOK price $25.68 -0.93 -3.49%
- Ticker
- STOK
- Price
- $25.68
- Change
- -0.93 -3.49%
- Market cap
- $1.66B
- P/E
- -7.92
- Forward P/E
- 11.99
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 51
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States. The company employs its exclusive Targeted Augmentation of Nuclear Gene Output (TANGO) platform to engineer ASOs that precisely enhance…